Leukemia m3 is a type of leukemia that can be cured for a long period of time, and it is a type of leukemia that has a better therapeutic effect at present. m3 leukemia, also known as acute promyelocytic leukemia, has a 10-year survival rate of more than 90% after cure. The main clinical manifestations of M3 leukemia are bone pain, fatigue, anemia, mental depression, etc. Some patients may have bleeding gums, nosebleeds, or gastrointestinal bleeding and other symptoms, which can be combined with disseminated intravascular coagulation in severe cases, and timely treatment measures should be taken. M3 leukemia is caused by a specific chromosomal mutation in hematopoietic cells, resulting in the fusion gene PML/RARA, which leads to the occurrence and development of the disease. This mutation can be treated with all-trans retinoic acid plus arsenite, or in combination with low-dose chemotherapy (cytarabine), which can achieve long-term remission without relapse in M3 leukemia. If you are diagnosed with M3 leukemia, you should cooperate with your doctor for active treatment. Early detection, diagnosis and treatment can effectively prolong the life of the patient.